For patients facing a grave illness, identifying a therapy is one thing.
Administering that therapy is often its own challenge, particularly
for those who may find it difficult to swallow a tablet.
Orally disintegrating tablets (ODTs), which dissolve on the tongue
in seconds, are a solution—but to make them, manufacturers
must balance dissolvability and fragility with strict regulations.
LGM Pharma overcame these challenges, ultimately delivering our
client’s niche product on-time and cost effectively.
